Literature DB >> 20603149

Lymphocyte activation in type 1 diabetes mellitus: the increased significance of Kv1.3 potassium channels.

Gergely Toldi1, Barna Vásárhelyi, Ambrus Kaposi, Gergo Mészáros, Pál Pánczél, Nóra Hosszufalusi, Tivadar Tulassay, András Treszl.   

Abstract

Kv1.3 and IKCa1 potassium channels participate in the maintenance of calcium-influx during lymphocyte activation. Kv1.3 channels have a prominent role in specific T cell subsets, presenting a possible target for selective immunomodulation. We investigated the impact of Kv1.3 and IKCa1 channel inhibitors on calcium-influx characteristics in human T cells in type 1 diabetes mellitus. We isolated lymphocytes from 9 healthy and 9 type 1 diabetic individuals and measured the alteration of calcium-influx with flow cytometry in the Th1, Th2, CD4 and CD8 subsets after treatment of samples with specific channel inhibitors. Our results indicate an increased reactivity of type 1 diabetes lymphocytes, which is correlated to their increased sensitivity to Kv1.3 channel inhibition. However, the contribution of Kv1.3 channels to calcium flux is not exclusive for a specific lymphocyte subset as previous reports suggest, but is characteristic for each subset investigated. Therefore, the proposed inhibition of Kv1.3 channels as a novel therapeutic approach for the treatment of type 1 diabetes mellitus may have a major effect on overall lymphocyte function in this disease. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20603149     DOI: 10.1016/j.imlet.2010.06.009

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  15 in total

1.  Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family.

Authors:  Zong-Yun Chen; You-Tian Hu; Wei-Shan Yang; Ya-Wen He; Jing Feng; Bin Wang; Rui-Ming Zhao; Jiu-Ping Ding; Zhi-Jian Cao; Wen-Xin Li; Ying-Liang Wu
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

2.  The expression and functional evidence for voltage-dependent potassium channel Kv1.3 in lymphocytes during aging in spontaneously hypertensive rats.

Authors:  Ling-Peng Wang; Jian Luo; Hai-Feng Hu; Li Zhang; Ya-Li Li; Li-Man Ai; Yu-Ling Wang; Yi-Tong Ma; Hu-Yati Mu; Yue-Mei Hou
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Kinetic measurements using flow cytometry: new methods for monitoring intracellular processes.

Authors:  Gergő Mészáros; Balázs Szalay; Gergely Toldi; Ambrus Kaposi; Barna Vásárhelyi; András Treszl
Journal:  Assay Drug Dev Technol       Date:  2011-09-15       Impact factor: 1.738

Review 4.  Discovery of KV 1.3 ion channel inhibitors: Medicinal chemistry approaches and challenges.

Authors:  Špela Gubič; Louise A Hendrickx; Žan Toplak; Maša Sterle; Steve Peigneur; Tihomir Tomašič; Luis A Pardo; Jan Tytgat; Anamarija Zega; Lucija P Mašič
Journal:  Med Res Rev       Date:  2021-05-01       Impact factor: 12.944

Review 5.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

6.  Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.

Authors:  Lars Koch Hansen; Linda Sevelsted-Møller; Maj Rabjerg; Dorte Larsen; Tine Plato Hansen; Lone Klinge; Heike Wulff; Torben Knudsen; Jens Kjeldsen; Ralf Köhler
Journal:  J Crohns Colitis       Date:  2014-05-03       Impact factor: 9.071

7.  Cm28, a scorpion toxin having a unique primary structure, inhibits KV1.2 and KV1.3 with high affinity.

Authors:  Muhammad Umair Naseem; Edson Carcamo-Noriega; José Beltrán-Vidal; Jesus Borrego; Tibor G Szanto; Fernando Z Zamudio; Gustavo Delgado-Prudencio; Lourival D Possani; Gyorgy Panyi
Journal:  J Gen Physiol       Date:  2022-06-14       Impact factor: 4.000

8.  Effects of undenatured whey protein supplementation on CXCL12- and CCL21-mediated B and T cell chemotaxis in diabetic mice.

Authors:  Gamal Badr; Mohamed Mohany; Ali Metwalli
Journal:  Lipids Health Dis       Date:  2011-11-09       Impact factor: 3.876

9.  The antibody targeting the E314 peptide of human Kv1.3 pore region serves as a novel, potent and specific channel blocker.

Authors:  Xiao-Fang Yang; Yong Yang; Yi-Tian Lian; Zhao-Hui Wang; Xiao-Wei Li; Long-Xian Cheng; Jin-Ping Liu; Yan-Fu Wang; Xiang Gao; Yu-Hua Liao; Min Wang; Qiu-Tang Zeng; Kun Liu
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

Review 10.  Toxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune Diseases.

Authors:  Yipeng Zhao; Jie Huang; Xiaolu Yuan; Biwen Peng; Wanhong Liu; Song Han; Xiaohua He
Journal:  Toxins (Basel)       Date:  2015-05-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.